Cited by 10Glioma Diagnosis and TreatmentEpigenetics and DNA MethylationCancer-related molecular mechanisms research

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population

Palani, Mahalakshmi, Devan, Sabarinathan, Arunkumar, R., Vanisree, A. J.·2011·Medical Oncology

Abstract

Gliomas are the most common primary brain tumors in India. The main epigenetic modification in glioma is aberrant DNA methylation that is now renowned to be a common hallmark of brain tumors. This study was designed to determine the frequency of aberrant CpG island methylation in the promoter regions of p21 and p73 in different grades of glioma and to explore their respective chromosomal aberrations. Total of 160 patients with histologically confirmed grades of glioma (I, II, III, and IV) were included in the study. DNA samples from blood and brain tissues, including benign lesions were subjected to sodium bisulfite conversion and hypermethylation detection using methylation-specific PCR followed by RT-PCR. Western blotting was also carried out for p21 and its related protein, p53. A total of 124 of 160 glioma samples (77.5%) displayed CpG island hypermethylation of both p73, p21 genes associated with the loss of mRNA expression (P < 0.001) and the loss of protein expressions (p53 independent p21 expression). p73 gene showed increased methylation frequency in all grades, 40 of 60 (66%) glioblastomas and 16 of 30 (53.3%) anaplastic astrocytoma, 10 of 20(50%) oligodendrogliomas, 8 of 20 (40%) ependymoma, and low-grade glioma 6 of 20 (30%). The percentage of methylation significantly well correlated with the overall survival and also with chromosomal loss. Thus, the studied glioma patients among south Indians showed a high frequency of aberrant methylation with varied chromosomal signatures in different grades, playing a role in aggressiveness and characterization of a particular grade, the appreciation of which might help for designing a specific therapy.

Integrity signals

Registry

Crossref · 10.1007/s12032-010-9671-4

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Methylation of the promoter regions of TP63 and TP73 corresponded with higher grade glioblastoma.

    “Indeed, methylation of the promoter regions of TP63 and TP73 corresponded with higher grade GBM [104].”

    From The p53 Pathway in Glioblastoma (2018) · cites this paper as [104]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Palani, M., Devan, S., Arunkumar, R., & Vanisree, A. J.
Affiliations
  • University of Madras (IN)
  • Madras Medical College (IN)
Corresponding author
Vanisree, A. J.
Venue
Medical Oncology
Published
2010-09-16
Volume
28
Issue
S1
Pages
445-452
ISSN
  • 1357-0560 (ISSN-L)
  • 1559-131X
OpenAlex
W2080979530
Cited by
10
References
26
Citations by year
2022: 1 · 2021: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
0.28
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
glioma, DNA methylation, p73, p21, CpG island hypermethylation, promoter hypermethylation, glioma grade, chromosomal abnormalities, glioblastoma, anaplastic astrocytoma, oligodendroglioma, ependymoma, p53, South Indian population
MeSH terms
Tumor Protein p73, Adolescent, Adult, Aged, Brain Neoplasms, Chromosome Aberrations, DNA-Binding Proteins, Female, Glioma, Humans, India, Male, Middle Aged, Nuclear Proteins, Genetic Variation, Gene Expression Regulation, Neoplastic, DNA Methylation, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p21, Young Adult, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review